From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Don’t miss out on your Early bird discount for IHCVHEC!

Share the link to this page with others to keep them informed

With keynote speakers announced and less than one month to secure early bird rates, this is your last chance to save on registration.

Don’t miss the opportunity to secure a seat at the International HIV Coinfection + Viral Hepatitis Elimination Conference. 

The early bird deadline date is 28 May 2023.

Register your place now >>  https://ihcvhec.com.au/registration-rates/

We are excited to announce that we will be joined by the below Keynote Speakers:

  • Alexandra King: Cameco Chair in Indigenous Health and Wellness at the University of Saskatchewan (USask), co-lead of Pewaseskwan (the Indigenous Wellness Research Group) and an Internist with the Saskatchewan Health Authority
  • Kate Seear: Australian Research Council Future Fellow and a Principal Research Fellow in the Australian Research Centre in Sex, Health and Society
  • Gilles Wandeler: physician at the Department of Infectious Diseases, Bern University Hospital, and a senior researcher at the Institute of Social and Preventive Medicine, University of Bern
  • James Ward: Indigenous Health at The University of Queensland

Find out more about our Keynote Speakers on our website.

Program sessions include:

  • Hepatitis B guidelines
  • New and emerging hepatitis C elimination strategies in Australia
  • Achieving triple elimination by 2030
  • “Turning of the tap”: the role of prevention in eliminating HIV and hepatitis C co-infection.